These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33106982)

  • 1. Low level of plasma fibulin-1 in patients with thyroid lesions: a case-control study and literature review.
    Hedayati M; Abooshahab R; Razavi SA; Salehipour P; Ahmadikia K; Boroomand S
    Mol Biol Rep; 2020 Nov; 47(11):8859-8866. PubMed ID: 33106982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers?
    Razavi SA; Modarressi MH; Yaghmaei P; Tavangar SM; Hedayati M
    Endocrine; 2017 Sep; 57(3):428-435. PubMed ID: 28755140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum concentrations of IGF-1 and IGF-1R in patients with thyroid cancers.
    Lawnicka H; Motylewska E; Borkowska M; Kuzdak K; Siejka A; Swietoslawski J; Stepien H; Stepien T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):77-83. PubMed ID: 31132076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.
    Yu H; Huang X; Liu X; Jin H; Zhang G; Zhang Q; Yu J
    Endocrine; 2013 Aug; 44(1):172-81. PubMed ID: 23264145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer.
    Zarkesh M; Zadeh-Vakili A; Akbarzadeh M; Fanaei SA; Hedayati M; Azizi F
    BMC Cancer; 2018 Dec; 18(1):1199. PubMed ID: 30509240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Plasma Levels of MT4-MMP and MT6-MMP; A New Observation in Patients with Thyroid Nodules.
    Shirazkeytabar K; Razavi SA; Abooshahab R; Salehipour P; Akbarzadeh M; Soroush A; Hedayati M; Nasiri S
    Arch Iran Med; 2023 Jun; 26(6):338-345. PubMed ID: 38310435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
    Hou X; Jiang L; Chen C; Zhu X; Ge M
    Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement C4-A and Plasminogen as Potential Biomarkers for Prediction of Papillary Thyroid Carcinoma.
    Wang Y; Zhou S; Wang D; Wei T; Zhu J; Li Z
    Front Endocrinol (Lausanne); 2021; 12():737638. PubMed ID: 34803909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?
    Ria R; Prete F; Melaccio A; Di Meo G; Saltarella I; Solimando AG; Gurrado A; Ferraro V; Pasculli A; Sgaramella LI; Racanelli V; Vacca A; Testini M
    Surgery; 2021 Jan; 169(1):27-33. PubMed ID: 32482341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
    Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma metabolites analysis of patients with papillary thyroid cancer: A preliminary untargeted
    Razavi SA; Mahmanzar M; Nobakht M Gh BF; Zamani Z; Nasiri S; Hedayati M
    J Pharm Biomed Anal; 2024 Apr; 241():115946. PubMed ID: 38241910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating miRNA95 and miRNA190 are sensitive markers for the differential diagnosis of thyroid nodules in a Caucasian population.
    Cantara S; Pilli T; Sebastiani G; Cevenini G; Busonero G; Cardinale S; Dotta F; Pacini F
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4190-8. PubMed ID: 25057879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered TEG Parameters Identify Hypercoagulablilty and are of Diagnosis Value for Papillary Thyroid Carcinoma Patients.
    Lu S; Kang R; Wang Y; Zhu M; Zhao L; Xu Q; Song Y; Liu C
    Exp Clin Endocrinol Diabetes; 2020 May; 128(5):297-302. PubMed ID: 30235493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid autoimmunity: is really associated with papillary thyroid carcinoma?
    Selek A; Cetinarslan B; Tarkun I; Canturk Z; Ustuner B; Akyay Z
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1677-1681. PubMed ID: 27933384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Use of 1-25-dihydroxyvitamin D in the Diagnosis and Treatment of Papillary Thyroid Cancer.
    Zhang T; Zhang H; He L; Wang Z; Dong W; Sun W; Zhang P
    Med Sci Monit; 2018 Mar; 24():1614-1623. PubMed ID: 29553126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment Of Plasma B-Catenin Concentration As Biomarker Of Thyroid Cancer.
    Bełdowski M
    Pol Przegl Chir; 2015 Jul; 87(7):340-5. PubMed ID: 26351788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
    Huang FQ; Li J; Jiang L; Wang FX; Alolga RN; Wang MJ; Min WJ; Ma G; Zhao YJ; Wang SL; Yu Y; Chen X; Zhu D; Zhu J; Wang G; Xia T; Sang JF; Lai MD; Li P; Zhu W; Qi LW
    Int J Cancer; 2019 Feb; 144(4):868-876. PubMed ID: 30318614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing.
    Pan Q; Zhao J; Li M; Liu X; Xu Y; Li W; Wu S; Su Z
    Carcinogenesis; 2020 Mar; 41(1):18-24. PubMed ID: 31560760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New evidence on tumor suppressor activity of PTEN and KLLN in papillary thyroid carcinoma.
    Razavi SA; Salehipour P; Gholami H; Sheikholeslami S; Zarif-Yeganeh M; Yaghmaei P; Modarressi MH; Hedayati M
    Pathol Res Pract; 2021 Sep; 225():153586. PubMed ID: 34425332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.